Financhill
Back

Enfusion 10K Form

Buy
56

ENFN
Enfusion

Last Price:
9.70
Seasonality Move:
-16.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ENFN News And Ratings

See the #1 stock for the next 7 days that we like better than ENFN

ENFN Financial Statistics

Sales & Book Value

Annual Sales: $174.54M
Cash Flow: $13.39M
Price / Cash Flow: 53.53
Annual Sales: $0.75
Price / Book: 12.82

Profitability

EPS (TTM): 0.04000
Net Income (TTM): $3.33M
Gross Margin: $116.89M
Return on Equity: 3.97%
Return on Assets: 2.88%

Enfusion Earnings Forecast

Key Enfusion Financial Ratios

  • The Gross Profit Margin over the past 5 years for ENFN is 66.97%.
  • The Selling, General & Administrative Expenses for ENFN have been equal to 48.73% of Gross Profit Margin.
  • The Research & Development expenses have been 11.40% of Revenue.
  • The Interest Expense is -2.90% of Operating Income.
  • The Net Earning history of ENFN is 3.45% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Enfusion Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Software
Sector: Information Technology
Current Symbol: ENFN
Website: enfusion.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.62
Quick Ratio: 3.41

Price-to-Earnings

Trailing P/E Ratio: 135.71
Forward P/E Ratio: 32.79

ENFN Technical Analysis vs Fundamental Analysis

Buy
56
Enfusion (ENFN) is a Buy

Is Enfusion a Buy or a Sell?

  • Enfusion stock is rated a Buy
    The current Enfusion [ENFN] share price is $9.50. The Score for ENFN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.